Baratte, Clement
Willemetz, Alexandra
Ribeiro-Parenti, Lara
Carette, Claire
Msika, Simon
Bado, Andre
Czernichow, Sebastien
Le Gall, Maude
Poghosyan, Tigran http://orcid.org/0000-0002-7103-1088
Article History
Received: 18 June 2022
Revised: 12 January 2023
Accepted: 19 January 2023
First Online: 2 February 2023
Declarations
:
: All animal studies comply with the ARRIVE guidelines. They were conducted in accordance with EU directive 2010/63/EU for animal experiments and approved by the Institutional Animal Care and Use Committee (CEA N° 121) and the French Ministry of Higher Education.
: Informed consent does not apply.
: Claire Carette reported personal fees from Ipsen Pharma, Pfizer, AstraZeneca, Novo Nordisk, Lilly, Vitalaire, and Merck France outside the submitted work. Sebastien Czernichow reported participation fees from Mygoodlife; personal fees from Novonordisk, Fresenius, Lilly, Janssen, and Bristol Myers Squibb; and other fees from Jellynov outside the submitted work. Tigran Poghosyan reported receiving personal fees from BariaTek, Novo Nordisk, and Gore outside the submitted work. No other disclosures were reported.